QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES

DEAD

Serial Number

90287732

Owner

SUPERNUS PHARMACEUTICALS, INC.

Attorney

Mark Simpson

Filing Date

Oct 29, 2020

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES Trademark

Serial Number: 90287732

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES is a trademark filed by SUPERNUS PHARMACEUTICALS, INC. on October 29, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

SUPERNUS PHARMACEUTICALS, INC. (49 trademarks)

1550 EAST GUDE DRIVE
ROCKVILLE, MD 20850

Entity Type: 03

Legal Representation

Attorney of Record

Mark Simpson

7 trademarks filed View all →

Trademark Details

Filing Date

October 29, 2020

Registration Date

Not Registered

Published for Opposition

June 1, 2021

Goods & Services

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders; all containing Viloxazine

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Aug 29, 2022 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Aug 29, 2022 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 29, 2022 EXRA

SOU EXTENSION 1 GRANTED

Jan 27, 2022 EX1G

SOU EXTENSION 1 FILED

Jan 27, 2022 EXT1

SOU TEAS EXTENSION RECEIVED

Jan 27, 2022 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 27, 2021 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 1, 2021 NPUB

PUBLISHED FOR OPPOSITION

Jun 1, 2021 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 12, 2021 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Apr 28, 2021 PREV

ASSIGNED TO LIE

Apr 28, 2021 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 28, 2021 CNSA

EXAMINER'S AMENDMENT ENTERED

Apr 27, 2021 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 27, 2021 GNEN

EXAMINERS AMENDMENT E-MAILED

Apr 27, 2021 GNEA

EXAMINERS AMENDMENT -WRITTEN

Apr 27, 2021 CNEA

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Apr 26, 2021 ZZZX

WITHDRAWN FROM PUB - OG REVIEW QUERY

Apr 20, 2021 PBCR

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 5, 2021 CNSA

EXAMINER'S AMENDMENT ENTERED

Apr 5, 2021 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 5, 2021 GNEN

EXAMINERS AMENDMENT E-MAILED

Apr 5, 2021 GNEA

EXAMINERS AMENDMENT -WRITTEN

Apr 5, 2021 CNEA

ASSIGNED TO EXAMINER

Mar 30, 2021 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Dec 24, 2020 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 23, 2020 NWOS

NEW APPLICATION ENTERED

Nov 2, 2020 NWAP

Related Trademarks

More from this Owner

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

More in Same Class

INVIZYNE

PIXOTINE